Vaxinia
Vaxinia Or known as C33-hNIS is an Oncolytic Species of Virus Made for the user of killing Cancer Cells And while avoiding Human Cells It was Genetically Modified.
History[edit]
C33-hNIS Went on Trial in 2022 And During May 17th, 2022, the First Phase of Clinical Testing Started with a Patient With Solid Tumors[1][2] and the First Clinical Trial will end by 2025 Or expected to ,It Has Two Current Types Of it Which can Either be Injected into the Tumor directly Or Into a Blood Vein Or Vessel And during Trials Was Actually Beneficial to The Immune System Due to a Antibody Named Pembrolizumab which accordingly To Imugene.
Other Articles[edit]
References[edit]
- ↑ "Human Injected With Cancer-killing Virus Vaxinia". MSN. Retrieved 2022-05-25.
- ↑ "First human patient injected with revolutionary cancer-killing virus". news.yahoo.com. Retrieved 2022-05-25.
This article "Vaxinia" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Vaxinia. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
